In 2001, Lumigan had been announced to the public as the cure for elevating hypertension in the eyes and glaucoma by the Food and Drug Administration, which is manufactured by Allergan, Inc.

Lumigan is an ophthalmic solution in the form of eye drops. It is released to the market for glaucoma and elevated intraocular pressure (eye hepertension). It is formulated in the laboratories of Allergan, Inc. and contains bimatoprost in its solution composition. Bimatoprost is the main and active compound which enables the lumigan to give positive results like reduction of eye hypertension and to people suffering from glaucoma.

However, Lumigan had extended its positive result to another condition occurs in the eye area, the hypotrichosis. Hypotrichosis is a condition of an abnormal growth of hair especially in the eye; the eyelashes.

Lumigan eyelashes treatment had started when the experts noticed the changes of patients who were under lumigan medication. Their eyelashes have transformed from short and dull to longer and, thick and full eyelashes. It was then that they have discovered that the active ingredient; the bimatoprost; can also cure hypotrichosis.

Lumigan eyelashes treatment does not only captured the attention of medically inclined individuals who specialize in hypotrichosis, likewise are the attention of those individuals; beauty experts, who are in continuous struggle into finding a remedy for dull eyelashes aside from mascara, fake eyelashes and lash dyes.

Lumigan eyelashes treatment has gained and continuously gaining the positive comments and testimonials by a lot of women, since women are the major user of lumigan eyelash treatment, the moment it was found out its effectiveness in growing eyelashes.

Since Lumigan was purposely produced by Allergan, Inc. for glaucoma, it was not recommended for hypotrichosis treatment. However, the Allegran had come to the idea of producing a new solution which will cater for the hypotrichosis alone. That was then the birth of Latisse. Since it is also the bimatoprost that makes the growth of the eyelashes possible, the same substance is put to the solution. But, given the fact that it is for hypotrichosis or for eyelash growth alone, the composition of the solution is of course altered.

The presence of Latisse had then created a feud between both solutions since both can be a treatment to hypotrichosis or eyelash growth. Although both are ophthalmic solutions, came from the same company and contain the same active ingredient, still it is strictly advised that one has to use the right solution for treatment, like for glaucoma, Lumigan must be used and Latisse for hypotrichosis to avoid serious and damaging effects.

And since both are similar in almost everything apart from its focus of treatment, it had been found out that both also are similar when it comes to side effect. Both posses substances that could possibly create pigmentations and causes discoloration to iris for lumigan and discoloration to skin around the eyelids for latisse.

However, for a better and best result, consult your physician as to which solution will he prescribe and would fit to your need f treatment.